Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1997
05/22/1997WO1997017968A1 Hemoregulatory compounds
05/22/1997WO1997017965A1 Hemoregulatory compounds
05/22/1997WO1997017964A1 Hemoregulatory compounds
05/22/1997WO1997017963A1 Hemoregulatory compounds
05/22/1997WO1997017961A1 Hemoregulatory compounds
05/22/1997WO1997017959A1 Hemoregulatory compounds
05/22/1997WO1997017958A1 Hemoregulatory compounds
05/22/1997WO1997017957A1 Hemoregulatory compounds
05/22/1997WO1997017949A1 Benzamidoxime prodrugs as antipneumocystic agents
05/22/1997WO1997017851A1 Hemoregulatory compounds
05/22/1997WO1997017850A1 Hemoregulatory compounds
05/22/1997CA2549534A1 Benzamidoxime prodrugs as antipneumocystic agents
05/22/1997CA2237998A1 Chemokine from niddm pancreas
05/22/1997CA2237783A1 E6 binding proteins
05/22/1997CA2237528A1 Chimeric oligomers having an rna-cleavage activity
05/22/1997CA2236236A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
05/22/1997CA2235394A1 Anti-viral isolates obtainable from leeches
05/21/1997EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER
05/21/1997EP0774466A1 Novel cephem derivatives
05/21/1997EP0774465A1 Penem derivatives and antimicrobial agents containing the same
05/21/1997EP0774262A1 Pharmaceutical compositions comprising a neutralized virus and use thereof
05/21/1997EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
05/21/1997EP0773957A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
05/21/1997EP0773956A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
05/21/1997EP0773951A1 Dinucleoside-5',5'-pyrophosphates
05/21/1997EP0773950A1 Linked peptide nucleic acids
05/21/1997EP0773943A1 Compounds useful as antiproliferative agents and garft inhibitors
05/21/1997EP0773926A1 Difluorostatone antiviral agents
05/21/1997EP0773791A1 Drug delivery composition for the nasal administration of antiviral agents
05/21/1997EP0773787A1 HLA binding peptides and their uses
05/21/1997EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv
05/21/1997EP0658195B1 Virus obtainable from human neuroblastoma cells
05/21/1997CN1150429A Cephalosporin compounds and processes for preparation thereof
05/21/1997CN1150428A Corticotropin releasing factor antagonists
05/21/1997CN1150424A Pyranone compounds useful to treat retroviral infections
05/21/1997CN1150153A Use of 2-amino-2,4,4,-trimethylpentane salt of clavulanic acid
05/21/1997CN1150033A Oral liquid for curing tuberculosis of lung
05/21/1997CN1150020A Anti-viral compounds
05/21/1997CN1034940C Preparation process for new cephalosporin
05/20/1997US5631366 Process for making 3-formylcephem derivatives
05/20/1997US5631283 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
05/20/1997US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders
05/20/1997US5631259 Cycloalkltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents
05/20/1997US5631256 Antimicrobial quinolone thioureas
05/20/1997US5631235 Immunosuppressants, antiarthritics and autoimmune diseases
05/20/1997US5631228 Anti-fungal and anti-bacterial histatin-based peptides
05/20/1997US5631223 Cyclic oligopeptides
05/20/1997US5631010 Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1
05/20/1997CA2091172C Antiviral compounds and antihypertensive compounds
05/18/1997CA2163163A1 Low-irritation anesthetic and antiseptic mouth rinse
05/15/1997WO1997017612A1 Prevention of sudden infant death
05/15/1997WO1997017449A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system
05/15/1997WO1997017433A1 Tissue-specific and target rna-specific ribozymes
05/15/1997WO1997017365A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
05/15/1997WO1997017357A1 3-deoxy-3-descladinose derivatives of erythromycins a and b
05/15/1997WO1997017356A1 Tricyclic erythromycin derivatives
05/15/1997WO1997017333A1 Benzoxazine antimicrobial agents
05/15/1997WO1997017085A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein
05/15/1997WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
05/15/1997WO1997016973A2 Natural composition for combatting fungi
05/15/1997WO1997011093A3 Parainfluenza virus glycoproteins and vaccines
05/15/1997WO1997001640A3 Vaccines against hepatitis c
05/15/1997WO1997001576A3 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
05/15/1997CA2235824A1 Cyclohexapeptidyl bisamine compound, compositions containing said compound and methods of use
05/15/1997CA2235681A1 3-deoxy-3-descladinose derivatives of erythromycins a and b
05/15/1997CA2234683A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system
05/14/1997EP0773295A2 DNA-based vaccination of fish by immersion
05/14/1997EP0773222A1 Novel carbapenem derivative
05/14/1997EP0773214A1 Trifluoromethylquinolinecarboxylic acid derivative
05/14/1997EP0773030A1 Method of purifying necrotoxin produced by bordetella and toxoid
05/14/1997EP0773025A1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process
05/14/1997EP0772689A2 Retroviral vectors having a reduced recombination rate
05/14/1997EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
05/14/1997EP0772680A1 A polynucleotide herpes virus vaccine
05/14/1997EP0772677A1 T cell activation
05/14/1997EP0772632A2 T cell stimulating protein of pestivirus
05/14/1997EP0772630A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
05/14/1997EP0772622A1 5'-dithio-modified oligonucleotides
05/14/1997EP0772619A1 Immunomodulatory oligonucleotides
05/14/1997EP0772617A1 7-o-carbamoyl heptose derivatives, process for their production and their use and screening process for their detection
05/14/1997EP0772615A1 IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
05/14/1997EP0772596A1 INDOLIZINE sPLA2 INHIBITORS
05/14/1997EP0772595A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
05/14/1997EP0772593A1 Thiopyridyl compounds for controlling helicobacter bacteria
05/14/1997EP0772592A1 1H-INDOLE-1-FUNCTIONAL sPLA 2? INHIBITORS
05/14/1997EP0772454A1 Antisense oligonucleotides against hepatitis b viral replication
05/14/1997EP0772445A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients
05/14/1997EP0772437A1 Compositions and methods for delivery of genetic material
05/14/1997EP0650365B1 Biocidal composition containing mustard seed plant extract
05/14/1997EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus
05/14/1997EP0629209B1 Sugar derivatives of macrolides
05/14/1997EP0603305B1 Use of a thymosin in the treatment of hepatitis c
05/14/1997CN1149888A 流感疫苗 Influenza vaccination
05/14/1997CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production
05/14/1997CN1149875A Quillaja saponin adjuvant and vaccine formulation containing same
05/14/1997CN1149835A Group A streptococcal polysaccharide immunogenic compositions and methods
05/14/1997CN1149831A Controlled-release dosage forms of azithromycin
05/14/1997CN1149829A Polymer coated tablet comprising amoxycillin and clavulanate
05/14/1997CN1149588A Cyclic bonding inhibitor
05/14/1997CN1149489A Recovering powder for hepatitis B
1 ... 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 ... 1798